Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Aspen Pharmacare Holdings plc (OTC: APNHY).

Full DD Report for APNHY

You must become a subscriber to view this report.


Recent News from (OTC: APNHY)

Aspen Pharmacare Holdings Plc ADR 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Aspen Pharmacare Holdings plc ADR in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: March, 09 2018 13:32
Mylan and Aspen Announce Launch of Generic Busulfex® Injection
HERTFORDSHIRE, England , PITTSBURGH and DURBAN, South Africa , Dec. 4, 2017 /PRNewswire/ --  Mylan N.V. (NASDAQ, TASE: MYL) and its partner, Aspen (JSE: APN), today announced the U.S. launch of Myleran (busulfan) Injection, 60 mg/10 mL (6 mg/mL) Single-dose Vial, a gen...
Source: PR Newswire
Date: December, 04 2017 07:30
Aspen Pharmacare Holdings (APNHY) Investor Presentation - Slideshow
The following slide deck was published by Aspen Pharmacare Holdings plc ADR in conjunction with this Read more ...
Source: SeekingAlpha
Date: November, 22 2017 13:16
Books will close today October 6th, 2017.
Books will close today October 6th, 2017.
Source: OTC Markets
Date: October, 06 2017 00:00
Aspen Pharmacare Has Continued To Grow And Branch Out
It has been many years since I've updated my coverage on South Africa's Aspen Pharmacare (APNHY)(APNJ.J), but the intervening years have seen a lot of familiar themes. Management has continued to use M&A to expand its market reach and has continued to expand beyond South Africa, while or...
Source: SeekingAlpha
Date: May, 17 2017 07:45
Wobbles Aside, Small Pharma Shares Broadly On The Up In 2015
The smaller the company the bigger the risk of massive shifts in valuation on a single catalyst. This truth is inescapable, and the biggest mid and small-cap share movers of 2015 show the risk and the rewards of investing in this sector. Last year showed that investors stood to gain more tha...
Source: SeekingAlpha
Date: January, 08 2016 06:39
Sector's Smaller Players Show The Way
With the Nasdaq biotech index proving remarkably resilient to sector-specific and macroeconomic problems alike, smart investors will continue to keep an eye out for signs of panic as a leading indicator of an overall collapse of sentiment. Nothing provides a better guide to the state of ...
Source: SeekingAlpha
Date: July, 04 2015 12:28
Opportunities And Risks In The Biotechnology Industry: 2 Companies In South Africa
The recent biotechnology industry boom, which has produced substantial returns for investors, should be met with equal levels of optimism and caution. Although clearly on the rise, the industry is being criticized for potentially being in a bubble and being a site for companies that consistent...
Source: SeekingAlpha
Date: June, 04 2015 06:20

 


About Aspen Pharmacare Holdings plc (OTC: APNHY)

Logo for Aspen Pharmacare Holdings plc (OTC: APNHY)

Not available

 

Contact Information

 

 

Current Management

  • Stephen Saad / CEO
  • Riaan Verster / Corporate Secretary

Current Share Structure

  • Market Cap: $10,737,185,058 - 03/09/2018
  • Issue and Outstanding: 472,379,457 - 07/30/2012

 



Daily Technical Chart for (OTC: APNHY)

Daily Technical Chart for (OTC: APNHY)


Stay tuned for daily updates and more on (OTC: APNHY)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: APNHY)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in APNHY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of APNHY and does not buy, sell, or trade any shares of APNHY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/